Business combinations and other acquisitions in in 2017. Pets and protein have never been more important,” Simmons said.
Indiana-based Elanco completed their acquisition of Bayer Animal Health on Monday. Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.
(RTTNews) - Elanco Animal Health Inc. (ELAN) announced Monday that it has closed the acquisition of Bayer Animal Health. “Nearly two years into our journey as an independent company, we have made significant progress in creating a purpose-driven, independent global company dedicated to animal health … Together, we have the potential to improve animal health and the lives of billions.”Simmons also says innovation will improve now that the two companies are one.
Elanco’s acquisition of Bayer’s animal health division, announced last August, created the world’s second largest company in the sector and was valued at $6.89 billion. The deal is valued at $6.9 billion. But, ultimately, today is about improving the lives of animals, people and improving the health of the planet. The US-based company Elanco has announced it has closed the acquisition of Bayer Animal Health. © Hoosier Ag Today Write CSS OR LESS and hit save. The transaction, valued at $6.89 billion, expands Elanco’s scale and capabilities, positioning the company for the long term as a leader in the attractive, durable animal health … The transaction was valued at $6.89 billion. Elanco now anticipates closing the deal Aug. 3.
The deal is valued at $6.9 billion.“Nearly two years into our journey as an independent company, we have made significant progress in creating a purpose-driven, independent global company dedicated to animal health – all while weathering the century’s most significant animal and human health pandemics: African Swine Fever and COVID-19,” said Jeff Simmons, president and CEO of Elanco.
Elanco has closed its purchase of Bayer Animal Health - a deal that is expected to propel the former to second in the industry rankings. Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has closed the acquisition of Bayer Animal Health. “Together, we are better positioned to advocate for our customers, to deliver solutions to their greatest unmet needs, so they can keep healthy, sustainably sourced meat, milk, fish and eggs in the center of the dinner table and healthy, active pets in the center of families. Jeff Simmons, president and CEO of Elanco, said: “Nearly two years into […]
While the timing of achieving goals from the deal announcement have been impacted by the COVID-19 pandemic, the company still expects to deliver $275 – $300 million in synergies by 2025.“Most importantly, today is about the farmers, veterinarians, and pet owners we serve. On January 3, 2017, Bayer Animal Health acquired the Cydectin™ portfolio in the United States from Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri, United States.
We know making life better for animals, simply makes life better.”The combined company brings together complementary farm animal portfolios that position Elanco to serve an even broader spectrum of the industry and better leverage data, and services for customers. Elanco Animal Health Incorporated has closed the acquisition of Bayer Animal Health.
They announced their intentions to acquire Bayer Animal Health in August of 2019.
Indiana-based Elanco completed their acquisition of Bayer Animal Health on Monday.
Bayer parent company receives US$5.17 billion in cash from US$6.89 billion deal. “Food supply disruptions and increasing unemployment are driving food security challenges around the world.